With decades of experience supporting early-stage drug development, United Pharmaceuticals Inc. delivers comprehensive preclinical research services aligned with scientific rigor and regulatory expectations. Our capabilities include a wide range of in vivo GLP and non-GLP safety assessment programs conducted across both rodent and non-rodent species. We support pharmaceutical compounds, biologics, veterinary products, agrochemical substances, and specialty chemical programs. Each program is customized to generate robust toxicology, safety pharmacology, and laboratory data.
Speak With Our Experts
As a reliable preclinical research partner, United Pharmaceuticals Inc. provides integrated CRO solutions that simplify and accelerate early drug development. Our experienced scientists focus on generating high-quality, decision-enabling data to support confident progression from lead optimization to first-in-human studies.
Comprehensive technical documentation and study insights offer sponsors clear visibility across all stages of preclinical development. Our expertise spans both small- and large-molecule research, supporting efficient milestone achievement and regulatory preparedness.
Preclinical programs at United Pharmaceuticals Inc. are structured to support sponsors at every stage of early development through integrated, full-service CRO capabilities. Our approach focuses on aligning scientific objectives with study design, execution, and data generation to meet regulatory and development goals.
By bringing multiple disciplines under a single operational framework, we ensure seamless coordination across formulation, analytical, and in vivo activities—supporting consistency, data integrity, and efficient project progression.
Study designs are supported by access to a wide range of animal models and administration routes selected based on scientific relevance and regulatory expectations. Our teams apply species-appropriate methodologies and dosing strategies to ensure accurate interpretation of safety and pharmacology outcomes.
From standard laboratory models to advanced nonhuman primate studies, each program is executed with controlled procedures and validated techniques.
Our scientists and technicians deliver reliable safety and toxicology studies designed to support both early development and regulatory submissions. Our safety assessment portfolio includes multiple preclinical study models aligned with global development and compliance requirements.
Our trained personnel adhere to established laboratory animal care standards, emphasizing ethical treatment, environmental enrichment, and responsible research practices. All studies are conducted in accordance with applicable animal welfare regulations and ethical guidelines, ensuring humane practices are maintained throughout study execution.
United Pharmaceuticals Inc. operates modern preclinical research facilities designed to support comprehensive safety evaluation and bioanalytical testing in both rodent and non-rodent species. Our infrastructure enables efficient execution of GLP and non-GLP programs across a wide range of study types. Equipped to support pivotal toxicology, safety pharmacology, and laboratory investigations, our facilities accommodate both small- and large-molecule development while meeting global regulatory submission expectations.
Explore Our Facilities
